{"id":3522,"date":"2022-03-02T14:47:28","date_gmt":"2022-03-02T14:47:28","guid":{"rendered":"https:\/\/pharma-expertise.com\/?page_id=3522"},"modified":"2022-10-26T13:26:58","modified_gmt":"2022-10-26T13:26:58","slug":"pharmaceuticals-regulatory-affairs","status":"publish","type":"page","link":"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/","title":{"rendered":"Regulatory Affairs"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_fullwidth_image src=&#8221;https:\/\/pharma-expertise.com\/wp-content\/uploads\/2021\/10\/top_pharma-arzneimittel-min.jpg&#8221; alt=&#8221;Pharma &#038; Arzneimittel&#8221; title_text=&#8221;Arzneimittel&#8221; _builder_version=&#8221;4.17.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_fullwidth_image][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; custom_margin=&#8221;||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.17.3&#8243; text_font=&#8221;||||||||&#8221; text_line_height=&#8221;2em&#8221; header_font=&#8221;Manrope|600|||||||&#8221; header_text_color=&#8221;#20292f&#8221; header_font_size=&#8221;26px&#8221; header_line_height=&#8221;1.3em&#8221; header_2_font=&#8221;Manrope|600||on|||||&#8221; header_2_text_color=&#8221;#193b7a&#8221; header_2_font_size=&#8221;14px&#8221; header_2_letter_spacing=&#8221;1px&#8221; header_2_line_height=&#8221;1.2em&#8221; header_3_font=&#8221;Manrope|500|||||||&#8221; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.4em&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; header_2_font_size_tablet=&#8221;42px&#8221; header_2_font_size_phone=&#8221;32px&#8221; header_2_font_size_last_edited=&#8221;off|desktop&#8221; header_3_font_size_tablet=&#8221;28px&#8221; header_3_font_size_phone=&#8221;20px&#8221; header_3_font_size_last_edited=&#8221;on|phone&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Regulatory Affairs<\/h2>\n<h1>Our services for regulatory affairs<\/h1>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.17.3&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Manrope||||||||&#8221; text_text_color=&#8221;#6d7c90&#8243; header_font=&#8221;Manrope|600|||||||&#8221; custom_margin=&#8221;0px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>The ever-increasing requirements for pharmaceuticals must be implemented in an<strong> efficient regulatory affairs strategy<\/strong>. In order to prove the efficacy and tolerability of your drug, a scientifically sound and regulatory safe approach, careful documentation for regulatory submissions, and professional management of <a href=\"\/en\/clinical-studies\"><strong>clinical trials<\/strong><\/a> are required.<\/p>\n<p>This applies to new submissions through national approval procedures,<strong> MRP procedures (Mutual Recognition Procedure), DCP procedures (Decentralised Procedure), <\/strong>and<strong> CP procedures (Centralised Procedure).<\/strong> It also relevant to revisions of dossiers for new procedures or complex change notifications, variations including indication extension, change of contract manufacturer, change of primary packaging, new manufacturing method, a new name, claim changes, the change of a drug from Rx to OTC status, and marketing authorisation extensions (Renewal).<\/p>\n<p>Our <strong>project management<\/strong> accompanies you through <strong>individual variations<\/strong>. However, we also support the <strong>entire process<\/strong>, from the development of the strategy and its implementation to the submission and granting of marketing authorization. We also help you through our network to find another contract manufacturer, primary packaging material, other active ingredient manufacturers etc.<\/p>\n<p><strong>We are happy to support you! Just contact us.<\/strong><\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;\/en\/contact&#8221; button_text=&#8221;Make a consultation appointment&#8221; _builder_version=&#8221;4.17.3&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;13px&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#16918f&#8221; button_border_width=&#8221;4px&#8221; button_border_color=&#8221;#16918f&#8221; button_border_radius=&#8221;0px&#8221; button_font=&#8221;Manrope|||on|||||&#8221; button_icon=&#8221;&#x24;||divi||400&#8243; button_icon_color=&#8221;#FFFFFF&#8221; background_layout=&#8221;dark&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Service Section&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#f7f7f7&#8243; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;70px||70px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row admin_label=&#8221;Service Section Title&#8221; _builder_version=&#8221;4.16&#8243; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; animation_style=&#8221;fade&#8221; animation_direction=&#8221;top&#8221; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Title&#8221; _builder_version=&#8221;4.17.3&#8243; text_font=&#8221;Montserrat||||||||&#8221; text_text_color=&#8221;#747d88&#8243; text_line_height=&#8221;1.9em&#8221; header_font=&#8221;||||||||&#8221; header_2_font=&#8221;Manrope|600|||||||&#8221; header_2_text_color=&#8221;#20292f&#8221; header_2_line_height=&#8221;1.4em&#8221; text_orientation=&#8221;center&#8221; max_width=&#8221;700px&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;bottom&#8221; animation_intensity_slide=&#8221;4%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Our Regulatory Affairs Services:<\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;2&#8243; make_equal=&#8221;on&#8221; admin_label=&#8221;Services&#8221; _builder_version=&#8221;4.16&#8243; max_width=&#8221;80%&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; use_custom_width=&#8221;on&#8221; width_unit=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.17.3&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Regulatory strategies, regulatory procedures<\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.16&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Dossier preparation<\/strong><br \/>and <strong>revision<\/strong><br \/><strong>(CTD, eCTD)<\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.16&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Change notifications<\/strong><br \/><strong>(Variations)<\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.17.3&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Authority discussions<\/strong><br \/>(e.g. <strong>Scientific Advice<\/strong>)<\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;2&#8243; make_equal=&#8221;on&#8221; admin_label=&#8221;Services&#8221; _builder_version=&#8221;4.16&#8243; max_width=&#8221;80%&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; use_custom_width=&#8221;on&#8221; width_unit=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.17.3&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Consulting<\/strong> on<br \/><strong>clinical studies<\/strong><br \/>in the <strong>approval process<\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.17.3&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Expert opinions <\/strong>on <strong>preclinical (modules 2.4, 2.6 <\/strong>and <strong>4), clinical (modules 2.5, 2.7 <\/strong>and <strong>5),<\/strong> and<strong>\u00a0quality (modules 2.3 <\/strong>and <strong>3)<\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.16&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Medical opinions<\/strong><br \/>on <strong>pharmacology<\/strong>, <strong>toxicology<\/strong><br \/>and <strong>clinic<\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.16&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Labelling<\/strong><br \/><strong>(preparation <\/strong>of <strong>package inserts <\/strong>and <strong>technical information), readability user test<\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;2&#8243; make_equal=&#8221;on&#8221; admin_label=&#8221;Services&#8221; _builder_version=&#8221;4.16&#8243; max_width=&#8221;80%&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||40px||false|false&#8221; use_custom_width=&#8221;on&#8221; width_unit=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.17.3&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Creation<\/strong><br \/><strong>Investigational Medicinal Product Dossier (IMPD), Investigator Brochure (IB), study plan, study report form (CRF), final report,<\/strong> etc.<\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;&#x52;||divi||400&#8243; icon_color=&#8221;#16918f&#8221; image_icon_width=&#8221;60px&#8221; _builder_version=&#8221;4.17.3&#8243; header_font=&#8221;Montserrat|on|||&#8221; header_text_color=&#8221;#353740&#8243; header_font_size=&#8221;22px&#8221; header_line_height=&#8221;1.4em&#8221; body_font=&#8221;Manrope||||||||&#8221; body_text_color=&#8221;#6d7c90&#8243; text_orientation=&#8221;center&#8221; custom_padding=&#8221;30px|30px|30px|30px&#8221; animation_style=&#8221;zoom&#8221; border_width_all=&#8221;0px&#8221; border_color_all=&#8221;#dddddd&#8221; border_style_all=&#8221;solid&#8221; use_border_color=&#8221;on&#8221; border_color=&#8221;#dddddd&#8221; icon_font_size=&#8221;60px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Due Diligence<\/strong><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regulatory Affairs Our services for regulatory affairsThe ever-increasing requirements for pharmaceuticals must be implemented in an efficient regulatory affairs strategy. In order to prove the efficacy and tolerability of your drug, a scientifically sound and regulatory safe approach, careful documentation for regulatory submissions, and professional management of clinical trials are required. This applies to new [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"class_list":["post-3522","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA approval \u00bb Drug Regulatory Affairs &amp; FDA drug registration<\/title>\n<meta name=\"description\" content=\"Our drug regulatory affairs services: approval procedures \u2714 US FDA \u2714 European EMA \u2714 BfArM \u2714 DCP \u2714 MRP \u2714 CP \u2714 change notifications \u2794 Contact.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approval \u00bb Drug Regulatory Affairs &amp; FDA drug registration\" \/>\n<meta property=\"og:description\" content=\"Our drug regulatory affairs services: approval procedures \u2714 US FDA \u2714 European EMA \u2714 BfArM \u2714 DCP \u2714 MRP \u2714 CP \u2714 change notifications \u2794 Contact.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Expertise Consulting\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-26T13:26:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-expertise.com\\\/en\\\/pharmaceuticals-regulatory-affairs\\\/\",\"url\":\"https:\\\/\\\/pharma-expertise.com\\\/en\\\/pharmaceuticals-regulatory-affairs\\\/\",\"name\":\"FDA approval \u00bb Drug Regulatory Affairs & FDA drug registration\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-expertise.com\\\/#website\"},\"datePublished\":\"2022-03-02T14:47:28+00:00\",\"dateModified\":\"2022-10-26T13:26:58+00:00\",\"description\":\"Our drug regulatory affairs services: approval procedures \u2714 US FDA \u2714 European EMA \u2714 BfArM \u2714 DCP \u2714 MRP \u2714 CP \u2714 change notifications \u2794 Contact.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-expertise.com\\\/en\\\/pharmaceuticals-regulatory-affairs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-expertise.com\\\/en\\\/pharmaceuticals-regulatory-affairs\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-expertise.com\\\/en\\\/pharmaceuticals-regulatory-affairs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-expertise.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regulatory Affairs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-expertise.com\\\/#website\",\"url\":\"https:\\\/\\\/pharma-expertise.com\\\/\",\"name\":\"Pharma Expertise Consulting\",\"description\":\"Your expert in pharma solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-expertise.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA approval \u00bb Drug Regulatory Affairs & FDA drug registration","description":"Our drug regulatory affairs services: approval procedures \u2714 US FDA \u2714 European EMA \u2714 BfArM \u2714 DCP \u2714 MRP \u2714 CP \u2714 change notifications \u2794 Contact.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/","og_locale":"en_US","og_type":"article","og_title":"FDA approval \u00bb Drug Regulatory Affairs & FDA drug registration","og_description":"Our drug regulatory affairs services: approval procedures \u2714 US FDA \u2714 European EMA \u2714 BfArM \u2714 DCP \u2714 MRP \u2714 CP \u2714 change notifications \u2794 Contact.","og_url":"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/","og_site_name":"Pharma Expertise Consulting","article_modified_time":"2022-10-26T13:26:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/","url":"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/","name":"FDA approval \u00bb Drug Regulatory Affairs & FDA drug registration","isPartOf":{"@id":"https:\/\/pharma-expertise.com\/#website"},"datePublished":"2022-03-02T14:47:28+00:00","dateModified":"2022-10-26T13:26:58+00:00","description":"Our drug regulatory affairs services: approval procedures \u2714 US FDA \u2714 European EMA \u2714 BfArM \u2714 DCP \u2714 MRP \u2714 CP \u2714 change notifications \u2794 Contact.","breadcrumb":{"@id":"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-expertise.com\/en\/pharmaceuticals-regulatory-affairs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-expertise.com\/en\/"},{"@type":"ListItem","position":2,"name":"Regulatory Affairs"}]},{"@type":"WebSite","@id":"https:\/\/pharma-expertise.com\/#website","url":"https:\/\/pharma-expertise.com\/","name":"Pharma Expertise Consulting","description":"Your expert in pharma solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-expertise.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/pharma-expertise.com\/en\/wp-json\/wp\/v2\/pages\/3522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-expertise.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pharma-expertise.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-expertise.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-expertise.com\/en\/wp-json\/wp\/v2\/comments?post=3522"}],"version-history":[{"count":5,"href":"https:\/\/pharma-expertise.com\/en\/wp-json\/wp\/v2\/pages\/3522\/revisions"}],"predecessor-version":[{"id":3910,"href":"https:\/\/pharma-expertise.com\/en\/wp-json\/wp\/v2\/pages\/3522\/revisions\/3910"}],"wp:attachment":[{"href":"https:\/\/pharma-expertise.com\/en\/wp-json\/wp\/v2\/media?parent=3522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}